Journal
SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41598-020-80224-1
Keywords
-
Categories
Funding
- Czech Science Foundation [19-04099S]
- Ministry of Health of the Czech Republic (project for conceptual development of the research organization) [00023736]
- EU Operational Program OP VaVpI by the Ministry of Education, CZ [CZ.1.05/4.1.00/16.0340]
Ask authors/readers for more resources
Nucleophosmin mutations causing export from the nucleoli to the cytoplasm are common in AML, leading to altered functions. NSC348884 was studied as a potential inhibitor of NPM oligomerization, but was found to not inhibit oligomer formation, with cytotoxicity instead linked to cell adhesion signaling.
Nucleophosmin (NPM) mutations causing its export from the nucleoli to the cytoplasm are frequent in acute myeloid leukemia (AML). Due to heterooligomerization of wild type NPM with the AML-related mutant, the wild-type becomes misplaced from the nucleoli and its functions are significantly altered. Dissociation of NPM heterooligomers may thus restore the proper localization and function of wild-type NPM. NSC348884 is supposed to act as a potent inhibitor of NPM oligomerization. The effect of NSC348884 on the NPM oligomerization was thoroughly examined by fluorescence lifetime imaging with utilization of FRET and by a set of immunoprecipitation and electrophoretic methods. Leukemia-derived cell lines and primary AML cells as well as cells transfected with fluorescently labeled NPM forms were investigated. Our results clearly demonstrate that NSC348884 does not inhibit formation of NPM oligomers neither in vivo nor in vitro. Instead, we document that NSC348884 cytotoxicity is rather associated with modified cell adhesion signaling. The cytotoxic mechanism of NSC348884 has therefore to be reconsidered.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available